Immuneering Operating Income from 2010 to 2025

IMRX Stock

USD 1.69 0.05 2.87%

Immuneering Corp Operating Income yearly trend continues to be fairly stable with very little volatility. Operating Income is likely to outpace its year average in 2025. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Immuneering Corp generates from its operations. View All Fundamentals

Operating Income

First Reported

2020-03-31

Previous Quarter

-15.3 M

Current Value

-18.6 M

Quarterly Volatility

4.6 M

Covid

Check Immuneering Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immuneering Corp's main balance sheet or income statement drivers, such as Net Interest Income of 2.7 M, Interest Income of 1.3 M or Depreciation And Amortization of 425.1 K, as well as many indicators such as Price To Sales Ratio of 207, Dividend Yield of 0.0 or PTB Ratio of 0.0017. Immuneering financial statements analysis is a perfect complement when working with Immuneering Corp Valuation or Volatility modules.

Check out the analysis of Immuneering Corp Correlation against competitors.

For more information on how to buy Immuneering Stock please use our How to Invest in Immuneering Corp guide.

Latest Immuneering Corp's Operating Income Growth Pattern

Below is the plot of the Operating Income of Immuneering Corp over the last few years. Operating Income is the amount of profit realized from Immuneering Corp operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Immuneering Corp is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Immuneering Corp's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immuneering Corp's overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Operating Income

Timeline

Immuneering Operating Income Regression Statistics

	Arithmetic Mean	(7,822,704,279)
	Geometric Mean	30,819,496
	Coefficient Of Variation	(272.80)
	Mean Deviation	13,661,727,924
	Median	(6,291,014)
	Standard Deviation	21,339,993,690
	Sample Variance	455395330.7T
	Range	64.1B
	R-Value	(0.57)
	Mean Square Error	327629147.6T
	R-Squared	0.33
	Significance	0.02
	Slope	(2,569,116,290)
	Total Sum of Squares	6830929960.3T

Immuneering Operating Income History

	2025	-60.9 B
	2024	-64.1 B
	2023	-58.4 M
	2022	-51.7 M
	2021	-33.9 M
	2020	-17.1 M

Other Fundumenentals of Immuneering Corp

Non Operating Income Net Other

Immuneering Corp Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Common Stock	Property Plant Equipment	Short Term Debt	Capital Surpluse	Intangible Assets	Current Deferred Revenue
Total Assets		1.0	0.42	-1.0	-1.0	0.42	-0.55	1.0	0.23	1.0	0.54	-0.04	0.54	0.5	0.56	0.96	-0.9	-0.95
Total Stockholder Equity	1.0		0.42	-1.0	-1.0	0.42	-0.55	1.0	0.23	1.0	0.54	-0.03	0.54	0.5	0.56	0.96	-0.9	-0.95
Net Tangible Assets	0.42	0.42		-0.43	-0.43	0.79	-0.61	0.42	0.94	0.42	0.97	0.84	0.97	0.86	0.93	0.53	-0.58	-0.34
Net Debt	-1.0	-1.0	-0.43		1.0	-0.42	0.55	-1.0	-0.23	-1.0	-0.55	0.04	-0.55	-0.52	-0.56	-0.97	0.89	0.93
Retained Earnings	-1.0	-1.0	-0.43	1.0		-0.42	0.55	-1.0	-0.22	-1.0	-0.55	0.04	-0.55	-0.52	-0.56	-0.97	0.89	0.93
Accounts Payable	0.42	0.42	0.79	-0.42	-0.42		-0.53	0.42	0.75	0.42	0.87	0.69	0.87	0.94	0.92	0.52	-0.65	-0.39
Net Receivables	-0.55	-0.55	-0.61	0.55	0.55	-0.53		-0.55	-0.52	-0.55	-0.7	-0.22	-0.7	-0.56	-0.73	-0.62	0.74	0.52
Total Liab	1.0	1.0	0.42	-1.0	-1.0	0.42	-0.55		0.23	1.0	0.54	-0.04	0.54	0.5	0.55	0.96	-0.9	-0.95
Net Invested Capital	0.23	0.23	0.94	-0.23	-0.22	0.75	-0.52	0.23		0.23	0.88	0.94	0.88	0.73	0.87	0.28	-0.44	-0.24
Total Current Assets	1.0	1.0	0.42	-1.0	-1.0	0.42	-0.55	1.0	0.23		0.54	-0.04	0.54	0.5	0.56	0.96	-0.9	-0.95
Capital Stock	0.54	0.54	0.97	-0.55	-0.55	0.87	-0.7	0.54	0.88	0.54		0.74	1.0	0.94	0.98	0.65	-0.73	-0.46
Net Working Capital	-0.04	-0.03	0.84	0.04	0.04	0.69	-0.22	-0.04	0.94	-0.04	0.74		0.74	0.66	0.72	0.04	-0.17	0.04
Common Stock	0.54	0.54	0.97	-0.55	-0.55	0.87	-0.7	0.54	0.88	0.54	1.0	0.74		0.94	0.98	0.65	-0.73	-0.46
Property Plant Equipment	0.5	0.5	0.86	-0.52	-0.52	0.94	-0.56	0.5	0.73	0.5	0.94	0.66	0.94		0.93	0.65	-0.7	-0.4
Short Term Debt	0.56	0.56	0.93	-0.56	-0.56	0.92	-0.73	0.55	0.87	0.56	0.98	0.72	0.98	0.93		0.65	-0.75	-0.5
Capital Surpluse	0.96	0.96	0.53	-0.97	-0.97	0.52	-0.62	0.96	0.28	0.96	0.65	0.04	0.65	0.65	0.65		-0.88	-0.83
Intangible Assets	-0.9	-0.9	-0.58	0.89	0.89	-0.65	0.74	-0.9	-0.44	-0.9	-0.73	-0.17	-0.73	-0.7	-0.75	-0.88		0.9
Current Deferred Revenue	-0.95	-0.95	-0.34	0.93	0.93	-0.39	0.52	-0.95	-0.24	-0.95	-0.46	0.04	-0.46	-0.4	-0.5	-0.83	0.9

Click cells to compare fundamentals

About Immuneering Corp Financial Statements

Immuneering Corp investors use historical fundamental indicators, such as Immuneering Corp's Operating Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Immuneering Corp. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Operating Income	-64.1 B	-60.9 B
Non Operating Income Net Other	1.4 M	1.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Immuneering Stock Analysis

When running Immuneering Corp's price analysis, check to measure Immuneering Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immuneering Corp is operating at the current time. Most of Immuneering Corp's value examination focuses on studying past and present price action to predict the probability of Immuneering Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immuneering Corp's price. Additionally, you may evaluate how the addition of Immuneering Corp to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Immuneering Operating Income from 2010 to 2025

Latest Immuneering Corp's Operating Income Growth Pattern

Immuneering Operating Income Regression Statistics

Immuneering Operating Income History

Other Fundumenentals of Immuneering Corp

Immuneering Corp Operating Income component correlations

About Immuneering Corp Financial Statements

Also Currently Popular

Additional Tools for Immuneering Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY